navacaprant - SERP Analysis

https://en.wikipedia.org/wiki/Navacaprant

https://ir.neumoratx.com/news-releases/news-release-details/neumora-therapeutics-reports-data-koastal-1-study-navacaprant

https://pubmed.ncbi.nlm.nih.gov/40199329/

https://www.psychiatrictimes.com/view/navacaprant-for-major-depressive-disorder-fails-in-late-stage-study

https://neumoratx.com/pipeline/

https://www.sciencedirect.com/science/article/pii/S0028390824002065

https://www.biospace.com/drug-development/neumora-shakes-up-phase-iii-mdd-trials-after-january-miss

https://www.pharmacytimes.com/view/navacaprant-did-not-show-statistically-significant-improvements-when-treating-patients-with-major-depressive-disorder

https://www.biologicalpsychiatryjournal.com/article/S0006-3223(24)00132-X/pdf

https://www.clinicaltrials.gov/ct2/show/NCT04221230

https://pmc.ncbi.nlm.nih.gov/articles/PMC12105956/

https://www.psychiatrictimes.com/view/navacaprant-a-hot-topic-at-the-acnp-2023-annual-meeting

https://www.medchemexpress.com/navacaprant.html?srsltid=AfmBOorhg-hx_PZLHD2JSd7_ClHcAkNAQeOY7GB2L-BjJ8jDqxPqOO1Y

https://www.fiercebiotech.com/biotech/neumora-halts-trial-depression-drug-rethinks-2-others-apply-learnings-phase-3-failure

https://firstwordpharma.com/story/5939222

https://www.sciencedirect.com/science/article/abs/pii/S0165032724010863

https://www.europeanpharmaceuticalreview.com/news/184722/efficacy-of-novel-drug-proven-in-mdd-study/

https://www.biologicalpsychiatryjournal.com/article/S0006-3223(24)00132-X/fulltext

https://www.biospace.com/drug-development/neumoras-novel-depression-drug-strikes-out-in-first-pivotal-trial

https://adisinsight.springer.com/drugs/800054451

https://synapse.patsnap.com/article/what-is-navacaprant-used-for

https://www.hcplive.com/view/phase-3-koastal-1-trial-fails-show-navacaprant-significantly-improves-mdd

https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=clinical&ligandId=10452

https://www.patientcareonline.com/view/neumora-therapeutics-reports-disappointing-results-from-phase-3-study-of-navacaprant-in-mdd

https://www.biopharmadive.com/news/neumora-depression-drug-data-results-stock-navacaprant/736263/

https://www.pharmaceutical-technology.com/data-insights/navacaprant-hydrochloride-neumora-therapeutics-bipolar-disorder-manic-depression-likelihood-of-approval/

https://www.kegg.jp/entry/D12869

https://synapse.patsnap.com/drug/d460210ca63b41c38c09bc578c9f4ebb

https://firstwordpharma.com/story/5846940

https://searchusan.ama-assn.org/usan/documentDownload?uri=/unstructured/binary/usan/navacaprant-HCl.pdf

https://www.contractpharma.com/breaking-news/neumoras-kostal-1-study-of-navacaprant-yields-disappointing-results/

https://pipelinereview.com/neumora-therapeutics-announces-initiation-of-phase-3-clinical-program-for-navacaprant-nmra-140-in-major-depressive-disorder/

https://www.medthority.com/news/2025/1/--results-from-phase-iii-koastal-1-study-of-navacaprant-for-major-depressive-disorder-did-not-demonstrate-a-statistically--significant-improvement.--neumora-therapeutics

https://www.globenewswire.com/news-release/2025/01/02/3003449/0/en/Neumora-Therapeutics-Reports-Data-from-KOASTAL-1-Study-of-Navacaprant-in-Major-Depressive-Disorder.html

https://www.pharmaceutical-technology.com/data-insights/navacaprant-hydrochloride-neumora-therapeutics-bipolar-ii-disorder-likelihood-of-approval/

https://www.practical-patient-care.com/news/neumora-therapeutics-announces-initiation-of-phase-3-clinical-program-for-navacaprant-in-major-depressive-disorder/

https://x.com/sanilrege/status/1814092729837883577

https://clinicaltrials.eu/inn/nmra-335140/

https://www.tandfonline.com/doi/full/10.1080/14728214.2024.2345645

https://x.com/endpts/status/1874847998100041757

https://www.fiercebiotech.com/biotech/neumora-stumbles-start-phase-3-depression-readout-run-sending-stock-down-80

https://www.linkedin.com/posts/neumora_neumora-therapeutics-announces-initiation-activity-7196102521742868480-iPz3

https://www.empr.com/news/navacaprant-falls-short-in-major-depressive-disorder-trial/

https://scholars.mssm.edu/en/clippings/neumora-therapeutics-announces-initiation-of-phase-3-clinical-pro-5

https://delta.larvol.com/Products/?ProductId=7303998b-2221-46c0-bfd1-f5736e95930a

https://finance.yahoo.com/news/neumora-therapeutics-navacaprant-did-not-122026841.html

https://www.biopharmadive.com/news/neumora-depression-drug-results-gosebruch-ceo/688253/

https://www.clinicaltrialvanguard.com/news/neumora-therapeutics-reports-positive-navacaprant-data-in-mdd/

https://www.chemenu.com/col/Navacaprant.html

https://www.europeanpharmaceuticalreview.com/drug/navacaprant-nmra-140/

https://clinicaltrials.gov/

https://clinconnect.io/trials/NCT06429722

https://www.sun-shinechem.com/Details/Navacaprant_(_BTRX-335140_)/5182/2244614-14-8.html

https://www.youtube.com/watch?v=2RAxhwCOp3g

https://www.nasdaq.com/articles/neumora-shares-plunge-navacaprant-misses-key-endpoints-major-depressive-disorder-trial

https://www.pharmacompass.com/chemistry-chemical-name/navacaprant

https://www.stocktitan.net/news/NMRA/neumora-therapeutics-reports-data-from-koastal-1-study-of-g4c5ublmnjfy.html

https://www.medchemexpress.com/search.html?q=Navacaprant&ft=&fa=&fp=&srsltid=AfmBOoqG3ljFUDSKZoeReS9iLMMQdSP0Uv5DV2W1FE4yjtMwb9RxlkH6

https://www.rttnews.com/3500253/neumora-shares-plunge-as-navacaprant-misses-key-endpoints-in-major-depressive-disorder-trial.aspx

https://qz.com/neumora-navacaprant-trial-results-1851731598

https://sigma.larvol.com/product.php?e1=806922&tab=newstrac

https://finance.yahoo.com/news/neumora-therapeutics-reports-data-koastal-120000066.html

https://www.marketscreener.com/quote/stock/NEUMORA-THERAPEUTICS-INC-159308146/news/Neumora-Therapeutics-Reports-Data-from-KOASTAL-1-Study-of-Navacaprant-in-Major-Depressive-Disorder-48674102/

https://labsolu.ca/product/navacaprant/

https://www.statnews.com/2025/01/02/neumora-therapeutics-antidepressant-clinical-trial-data/

https://endpts.com/neumoras-major-depression-drug-flunks-first-of-three-phase-3-trials/

https://www.ainvest.com/news/neumora-plunges-depression-drug-fails-final-stage-study-2501-4/

https://www.stocktitan.net/news/NMRA/neumora-therapeutics-announces-initiation-of-phase-2-study-of-2pkqiqx83gke.html

https://www.benzinga.com/pressreleases/24/05/g38810983/neumora-therapeutics-announces-initiation-of-phase-2-study-of-navacaprant-in-bipolar-depression

https://pharmaphorum.com/news/neumora-laid-low-depression-trial-failure

https://seekingalpha.com/article/4668522-neumora-phase-3-mdd-readout-2nd-half-of-2024-could-get-ball-rolling

https://www.moomoo.com/hans/news/post/53901192/earnings-call-summary-neumora-therapeutics-nmraus-q1-2025-earnings-conference